6533b838fe1ef96bd12a3e18

RESEARCH PRODUCT

Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes.

Rizzo ManfrediFrancesco CosentinoChristos Mantzoros

subject

Diabetes Mellitus Type 2Drugs GenericHumansHypoglycemic AgentsPharmacology (medical)General MedicineGeneral Pharmacology Toxicology and PharmaceuticsLiraglutideBiosimilar PharmaceuticalsGlucagon-Like Peptide-1 ReceptorBiosimilar GLP-1 diabetes generics liraglutide treatment10.1080/17512433.2022.2108400https://pubmed.ncbi.nlm.nih.gov/34473890